Transport function and transcriptional regulation of a liver-enriched human organic anion transporting polypeptide 2b1 transcriptional start site variant

Molecular Pharmacology

Volumn 83, Issue 6, 2013, Pages 1218-1228

  Knauer, Michael J ^a   Girdwood, Anthea J ^a   Kim, Richard B ^a   Tirona, Rommel G ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRONE SULFATE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTING POLYPEPTIDE 2B1; ROSUVASTATIN; SILICON; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL ASSAY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DUODENUM; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SILENCING; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; PROTEIN TRANSPORT; RADIOCHEMISTRY; RNA ISOLATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TRANSCRIPTIONAL START SITE VARIANT;

BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; LIVER; LUCIFERASES, RENILLA; MUTATION; ORGAN SPECIFICITY; ORGANIC ANION TRANSPORTERS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SEQUENCE DELETION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC;

EID: 84877831064     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.083618     Document Type: Article

References (41)

1. Aoki M, Terada T, Ogasawara K, Katsura T, Hatano E, Ikai I, and Inui K (2009) Impact of regulatory polymorphisms in organic anion transporter genes in the human liver. Pharmacogenet Genomics 19:647-656.
2. Bolotin E, Liao H, Ta TC, Yang C, Hwang-Verslues W, Evans JR, Jiang T, and Sladek FM (2010) Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays. Hepatology 51:642-653.
3. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, and Mangelsdorf DJ (2006) Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126:789-799. (Pubitemid 44233630)
4. Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, and Kim RB (1999) OATP and Pglycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 27:866-871. (Pubitemid 29347585)
5. Fang B, Mane-Padros D, Bolotin E, Jiang T, and Sladek FM (2012) Identification of a binding motif specific to HNF4 by comparative analysis of multiple nuclear receptors. Nucleic Acids Res 40:5343-5356.
6. Grube M, Köck K, Oswald S, Draber K, Meissner K, Eckel L, Böhm M, Felix SB, Vogelgesang S, and Jedlitschky G et al. (2006) Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart. Clin Pharmacol Ther 80:607-620. (Pubitemid 44920223)
7. Hagenbuch B and Meier PJ (2004) Organic anion transporting polypeptides of the OATP/ SLC21 family: Phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 447:653-665. (Pubitemid 38241451)
8. Ho RH, Tirona RG, Leake BF, Glaeser H, Lee W, Lemke CJ, Wang Y, and Kim RB (2006) Drug and bile acid transporters in rosuvastatin hepatic uptake: Function, expression, and pharmacogenetics. Gastroenterology 130:1793-1806.
9. Hwang-Verslues WW and Sladek FM (2010) HNF4a-role in drug metabolism and potential drug target? Curr Opin Pharmacol 10:698-705.
10. Jover R, Bort R, Gómez-Lechón MJ, and Castell JV (2001) Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: A study using adenovirus-mediated antisense targeting. Hepatology 33:668-675. (Pubitemid 32185230)
11. Jover R, Moya M, and Gómez-Lechón MJ (2009) Transcriptional regulation of cytochrome p450 genes by the nuclear receptor hepatocyte nuclear factor 4-alpha. Curr Drug Metab 10:508-519.
12. Kamiyama Y, Matsubara T, Yoshinari K, Nagata K, Kamimura H, and Yamazoe Y (2007) Role of human hepatocyte nuclear factor 4alpha in the expression of drugmetabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA. Drug Metab Pharmacokinet 22:287-298.
13. Kawashima S, Kobayashi K, Takama K, Higuchi T, Furihata T, Hosokawa M, and Chiba K (2006) Involvement of hepatocyte nuclear factor 4alpha in the different expression level between CYP2C9 and CYP2C19 in the human liver. Drug Metab Dispos 34:1012-1018. (Pubitemid 43763759)
14. Kis O, Zastre JA, Ramaswamy M, and Bendayan R (2010) pH dependence of organic anion-transporting polypeptide 2B1 in Caco-2 cells: Potential role in antiretroviral drug oral bioavailability and drug-drug interactions. J Pharmacol Exp Ther 334:1009-1022.
15. Knauer MJ, Urquhart BL, Meyer zu Schwabedissen HE, Schwarz UI, Lemke CJ, Leake BF, Kim RB, and Tirona RG (2010) Human skeletal muscle drug transporters determine local exposure and toxicity of statins. Circ Res 106:297-306.
16. Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, and Tamai I (2003) Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther 306:703-708. (Pubitemid 36886171)
17. Kopplow K, Letschert K, König J, Walter B, and Keppler D (2005) Human hepatobiliary transport of organic anions analyzed by quadruple- transfected cells. Mol Pharmacol 68:1031-1038. (Pubitemid 41345794)
18. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, and Hagenbuch B (2001) Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120:525-533. (Pubitemid 32147650)
19. Leuthold S, Hagenbuch B, Mohebbi N, Wagner CA, Meier PJ, and Stieger B (2009) Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. Am J Physiol Cell Physiol 296:C570-C582.
20. Maeda T, Hirayama M, Higashi R, Sato M, and Tamai I (2006) Characterization of human OATP2B1 (SLCO2B1) gene promoter regulation. Pharm Res 23:513-520.
21. Niessen J, Jedlitschky G, Grube M, Bien S, Schwertz H, Ohtsuki S, Kawakami H, Kamiie J, Oswald S, and Starke K et al. (2009) Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin. Drug Metab Dispos 37:1129-1137.
22. Nozawa T, Imai K, Nezu J, Tsuji A, and Tamai I (2004a) Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. J Pharmacol Exp Ther 308:438-445. (Pubitemid 38134202)
23. Nozawa T, Sugiura S, Nakajima M, Goto A, Yokoi T, Nezu J, Tsuji A, and Tamai I (2004b) Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: Implications for understanding troglitazone hepatotoxicity. Drug Metab Dispos 32:291-294. (Pubitemid 38263886)
24. Oswald S, König J, Lütjohann D, Giessmann T, Kroemer HK, Rimmbach C, Rosskopf D, Fromm MF, and Siegmund W (2008) Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1. Pharmacogenet Genomics 18:559-568.
25. Podvinec M, Kaufmann MR, Handschin C, and Meyer UA (2002) NUBIScan, an in silico approach for prediction of nuclear receptor response elements. Mol Endocrinol 16:1269-1279. (Pubitemid 34621075)
26. Pomari E, Nardi A, Fiore C, Celeghin A, Colombo L, and Dalla Valle L (2009) Transcriptional control of human organic anion transporting polypeptide 2B1 gene. J Steroid Biochem Mol Biol 115:146-152.
27. Popowski K, Eloranta JJ, Saborowski M, Fried M, Meier PJ, and Kullak-Ublick GA (2005) The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4 alpha and suppressed by bile acids. Mol Pharmacol 67:1629-1638. (Pubitemid 40594162)
28. Saborowski M, Kullak-Ublick GA, and Eloranta JJ (2006) The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4alpha. J Pharmacol Exp Ther 317:778-785.
29. Sai Y, Kaneko Y, Ito S, Mitsuoka K, Kato Y, Tamai I, Artursson P, and Tsuji A (2006) Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells. Drug Metab Dispos 34:1423-1431. (Pubitemid 44079886)
30. Satoh H, Yamashita F, Tsujimoto M, Murakami H, Koyabu N, Ohtani H, and Sawada Y (2005) Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 33:518-523. (Pubitemid 40393194)
31. Shirasaka Y, Mori T, Shichiri M, Nakanishi T, and Tamai I (2012) Functional pleiotropy of organic anion transporting polypeptide OATP2B1 due to multiple binding sites. Drug Metab Pharmacokinet 27:360-364.
32. Shirasaka Y, Suzuki K, Nakanishi T, and Tamai I (2010) Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide. Pharm Res 27:2141-2149.
33. Shirasaka Y, Suzuki K, Shichiri M, Nakanishi T, and Tamai I (2011) Intestinal absorption of HMG-CoA reductase inhibitor pitavastatin mediated by organic anion transporting polypeptide and P-glycoprotein/multidrug resistance 1. Drug Metab Pharmacokinet 26:171-179.
34. Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, and Tsuji A (2000) Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun 273:251-260. (Pubitemid 30426895)
35. Tamai I, Nozawa T, Koshida M, Nezu J, Sai Y, and Tsuji A (2001) Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C. Pharm Res 18:1262-1269. (Pubitemid 32846318)
36. Tirona RG, Leake BF, Wolkoff AW, and Kim RB (2003a) Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampinmediated pregnane X receptor activation. J Pharmacol Exp Ther 304:223-228. (Pubitemid 36008932)
37. Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V, Parviz F, Duncan SA, Inoue Y, and Gonzalez FJ et al. (2003b) The orphan nuclear receptor HNF4alpha determines PXR-and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 9: 220-224. (Pubitemid 36227725)
38. Treiber A, Schneiter R, Häusler S, and Stieger B (2007) Bosentan is a substrate of human OATP1B1 and OATP1B3: Inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. Drug Metab Dispos 35:1400-1407. (Pubitemid 47121782)
39. Ugele B, St-Pierre MV, Pihusch M, Bahn A, and Hantschmann P (2003) Characterization and identification of steroid sulfate transporters of human placenta. Am J Physiol Endocrinol Metab 284:E390-E398. (Pubitemid 36120113)
40. Urquhart BL, Gregor JC, Chande N, Knauer MJ, Tirona RG, and Kim RB (2010) The human proton-coupled folate transporter (hPCFT): Modulation of intestinal expression and function by drugs. Am J Physiol Gastrointest Liver Physiol 298: G248-G254.
41. Varma MV, Rotter CJ, Chupka J, Whalen KM, Duignan DB, Feng B, Litchfield J, Goosen TC, and El-Kattan AF (2011) pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1. Mol Pharm 8:1303-1313.